Study of Gene Expression Profiling and Immunological Mechanism Affects the Response of Immunotherapy
NCT01884168
·
clinicaltrials.gov ↗
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Malignant Tumor
Interventions
BIOLOGICAL:
Dc-CIK immunotherapy
Sponsor
Capital Medical University